Dashboard
Manage Tickers

CYTK CYTOKINETICS INC

Nasdaq cytokinetics.com


$ 57.01 $ 0.00 (0 %)    

Friday, 17-Oct-2025 07:11:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 597.32 $ 0.00 (0 %)
DIA $ 459.02 $ 0.00 (0 %)
SPY $ 659.02 $ 0.00 (0 %)
TLT $ 91.25 $ 0.00 (0 %)
GLD $ 395.50 $ 0.00 (0 %)
$ 58.96
$ 62.94
$ 57.00 x 52
$ 60.38 x 225
-- - --
$ 29.31 - $ 63.86
2,138,291
na
7.05B
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-04-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-07-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-05-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-06-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 03-03-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-cytokinetics-raises-price-target-to-82
Barclays Maintains Overweight on Cytokinet...
10/06/2025 13:00:38

Barclays analyst Gena Wang maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and raises the price target from $71 to $82.

b-of-a-securities-maintains-neutral-on-cytokinetics-raises-price-target-to-56
B of A Securities Maintains Neutral on Cyt...
10/02/2025 18:15:52

B of A Securities analyst Jason Zemansky maintains Cytokinetics (NASDAQ:CYTK) with a Neutral and raises the price target fro...

cal-maine-foods-posts-downbeat-earnings-joins-enanta-pharmaceuticals-aar-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Cal-Maine Foods Posts Downbeat Earnings, J...
10/01/2025 12:16:06

hc-wainwright--co-reiterates-buy-on-cytokinetics-maintains-120-price-target
HC Wainwright & Co. Reiterates Buy on Cyto...
09/29/2025 16:19:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ: CYTK) with a Buy and maintains $120 price ...

cytokinetics-presents-additional-data-related-to-aficamten-in-late-breaking-clinical-research-session-at-hfsa-annual-scientific-meeting-2025
Cytokinetics Presents Additional Data Rela...
09/29/2025 11:36:16

Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Re...

b-riley-securities-maintains-buy-on-cytokinetics-raises-price-target-to-80
B. Riley Securities Maintains Buy on Cytok...
09/22/2025 15:34:44

B. Riley Securities analyst Mayank Mamtani maintains Cytokinetics (NASDAQ:CYTK) with a Buy and raises the price target from ...

hc-wainwright--co-reiterates-buy-on-cytokinetics-maintains-120-price-target
HC Wainwright & Co. Reiterates Buy on Cyto...
09/22/2025 10:39:35

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $120 price t...

reported-earlier-cytokinetics-prices-upsized-650m-convertible-senior-notes-offering-at-175-coupon-extending-debt-maturity-to-2031
Reported Earlier, Cytokinetics Prices Upsi...
09/17/2025 06:43:23

on-sept-15-cytokinetics-participates-in-fda-late-cycle-meeting-for-nda-for-aficamten-pdufa-target-action-date-for-aficamten-nda-is-dec-26-2025--continues-to-expect-differentiated-label--risk-mitigation-profile-for-aficamten-if-approved-by-fda
On Sept 15, Cytokinetics Participates In F...
09/16/2025 20:15:34

-SEC Filing

cytokinetics-announces-550m-private-offering-of-convertible-notes-due-2031
Cytokinetics Announces $550M Private Offer...
09/16/2025 20:03:20

Cytokinetics, Incorporated ("Cytokinetics") (NASDAQ:CYTK) today announced its intention to offer, subject to market con...

barclays-maintains-overweight-on-cytokinetics-raises-price-target-to-71
Barclays Maintains Overweight on Cytokinet...
09/03/2025 14:17:29

Barclays analyst Gena Wang maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and raises the price target from $53 to $71.

evercore-isi-group-maintains-outperform-on-cytokinetics-raises-price-target-to-80
Evercore ISI Group Maintains Outperform on...
09/03/2025 13:38:42

Evercore ISI Group analyst Cory Kasimov maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and raises the price target f...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/02/2025 17:35:29

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

dow-tumbles-over-1-nio-shares-edge-lower-after-q2-results
Dow Tumbles Over 1%; Nio Shares Edge Lower...
09/02/2025 16:55:35

stifel-maintains-buy-on-cytokinetics-raises-price-target-to-96
Stifel Maintains Buy on Cytokinetics, Rais...
09/02/2025 15:15:37

Stifel analyst James Condulis maintains Cytokinetics (NASDAQ:CYTK) with a Buy and raises the price target from $87 to $96.

cytokinetics-cytk-stock-is-skyrocketing-tuesday-whats-driving-the-action
Cytokinetics (CYTK) Stock Is Skyrocketing ...
09/02/2025 14:46:24

Shares of Cytokinetics are trading sharply higher Tuesday. The company presented new long-term safety and efficacy data for its...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

jmp-securities-reiterates-market-outperform-on-cytokinetics-maintains-78-price-target
JMP Securities Reiterates Market Outperfor...
09/02/2025 13:58:56

JMP Securities analyst Jason N. Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $78 pric...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 12:08:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION